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ABSTRACT

Most of existing techniques cannot be used to detect molecular biomarkers (i.e., protein
and DNA) contained in complex body fluids due to issues such as enzyme inhibition or signal
interference. This thesis describes a nanoparticle-based thermal detection method for the highly
sensitive detections of multiple DNA biomarkers or proteins contained in different type of fluids
such as buffer solution, cell lysate and milk by using solid-liquid phase change nanoparticles as
thermal barcodes. Besides, this method has also been applied for thrombin detection by using
RNA aptamer-functionalized phase change nanoparticles as thermal probes. Furthermore, using
nanostructured Si surface that have higher specific area can enhance the detection sensitivity by
four times compared to use flat aluminum surfaces. The detection is based on the principle that
the temperature of solid will not rise above its melting temperature unless all solid is molten,
thus nanoparticles will have sharp melting peak during a linear thermal scan process. A
one-to-one correspondence can be created between one type of nanoparticles and one type of
biomarker, and multiple biomarkers can be detected simultaneously using different type
nanoparticles. The melting temperature and the heat flow reflect the type and the concentration
of biomarker, respectively. The melting temperatures of nanoparticles are designed to be over
100°C to avoid interference from species contained in fluids. The use of thermal nanoparticles
allows detection of multiple low concentration DNAs or proteins in a complex fluid such as cell
lysate regardless of the color, salt concentration, and conductivity of the sample.
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CHAPTER 1: INTRODUCTION

1.1 Cancer detection using biomarkers
Cancer is the result of genetic instability and accumulation of multiple molecular
alterations.1 Cancer can occur in all races. According to National Vital Statistics Reports
(2002-2006), among 100,000 persons, the numbers of cancer patients were 470.6 in White
people, 493.6 in Black people, 311.1 in Asians, and 350.6 in Hispanics, Among all forms of
cancers, lung cancer, breast cancer and prostate cancer are three leading causes of death in the
United States, claiming over 227,900 lives in 2007 alone. It has been found that if cancer could
be diagnosed at early stage and remains in the primary site, the five-year survival rate can
increase significantly. Unfortunately, not many cancers can be detected at early stage based on
current diagnostic techniques, and by the time when cancers are identified, significant spreading
of the cancer to other organ systems has occurred.
Normally people with pre-cancer symptoms such as unidentified bleeding will be asked
to take physical examinations such as computer tomography, X-ray, magnetic resonance imaging
(MRI) and biopsy.2-4 But, unless a large solid tumor is present, the diagnostic outcomes strongly
depend on the sensitivity of the method to detect cancer from the general tissue background, and
in most cases results have a high false positive rate. Traditional X-ray scan has a low resolution
and cannot identify cancers smaller than millimeters. Even with spiral computed tomography,
which is the most accurate technique available, bronchial cancers at early stage cannot be
detected. Computer tomography strongly depends on contrast agents to enhance image quality,
has low sensitivity, and agents themselves could have adverse effects on patients. Biopsy has
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been used for cancer detection, but the invasive nature of the process is painful for patient, and
small cancer may also not be detected. Another method to visualize lung cancer is to use
fiberoptic bronchoscopy, but it cannot be used for screening purpose due to its invasive nature;
meanwhile, such method can only identify large cancer tumors in main airways.5
The multistage growth of cancers is characterized by gradual accumulation of molecular
abnormalities, resulting in uncontrolled growth of cells. Such genetic abnormalities are involved
in a wide range of cell dynamics including cell cycles, senescence, apoptosis, cellular repair,
differentiation and migration. Recent advances in molecular biology have opened up many new
opportunities for the detection and diagnosis of cancer using genetic abnormalities or proteins as
biomarkers. Principally, it is possible to detect cancer earlier than current methods by detecting
cancer-related genes or proteins, before the appearance of observable abnormality at cell level.
However, a significant challenge is to turn this rich molecular biology knowledge into advances
in diagnosis. The main reason is that cancer genetic biomarkers are not effective, even in the case
of widely used prostate specific antigen (PSA).6 Meanwhile, these abnormal genes or proteins
almost always have very low concentration in a biologically diverse environment. The difference
between normal and cancer genes may be only base pair. In the case of protein, the concentration
of cancer-specific antigen may be too low and have a large protein background. Detecting a low
concentration DNA or protein of not-so-effective biomarkers under a huge background will be a
great challenge, will be very expensive for most of current techniques such as polymerase chain
reaction, and is not economically favorable for early screening.7 In order to establish an effective
cancer detection strategy, it would be appropriate to create a highly sensitive miniaturized device
which requires small amount of sample. Furthermore, it is desirable that multiple biomarkers can
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be detected to enhance detection reliability for reliable detection and screening at an early stage.
Such detections will leave sufficient time for effective treatment of cancer at an operable stage.
1.2 Existing methods of in vitro cancer biomarker detection
Biosensors have been attracting much attention and extensively studied over the last two
decades for diseases diagnostics and detection of biological molecules. Traditional biosensing
methods normally used for cancer biomarker detection include polymerase chain reaction (PCR),
enzyme-linked immunosorbent assay (ELISA), and DNA microarray.8-10 These approaches have
certain advantages such as high-throughput, and the ability for amplification, but these methods
cannot detect ultralow concentration of biomarkers, cannot perform readout in body fluids, and
need extensive sample preparation efforts.
1.2.1 Polymerase chain reaction
Polymerase chain reaction (PCR) was developed in 1983, and is a technique in molecular
biology to amplify a single or few copies of a piece of DNA segment by several orders of
magnitude, generating thousands to millions of copies of a particular DNA sequence. PCR is an
indispensable technique in medical and biological research labs for a variety of applications.11, 12
It allows early diagnosis of fatal diseases, such as leukemia and lymphomas, with high sensitivity
and identification of non-cultivatable or slow-growing microorganisms, such as mycobacteria,
anaerobic bacteria, or viruses. Besides, PCR assays can be carried out directly on genomic DNA
samples to detect translocation in specific malignant cells. The PCR diagnosis is based on the
detection of infectious agents and the discrimination of non-pathogenic from pathogenic strains
by specific genes. In the case of PCR based viral DNA detection, the primers used are specific to
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the target viral DNA sequences. The high sensitivity of PCR permits virus detection soon after
infection and before onset of disease, which gives physicians a significant lead in treatment. PCR
approach can detect all organisms regardless of physiological state and is fast and easy to
perform. However, PCR method has a big limitation: it is easy to pick up contaminants.
1.2.2 Enzyme-linked immunosorbent assay
Enzyme-linked immunosorbent assay (ELISA) has been used for detecting the presence
and concentration of a particular antibody or antigen in a fluid sample. The test procedure is as
follows (Figure 1.1): (1) prepare a surface and bind a known quantity of primary antibody to it;
(2) apply the antigen-containing sample to the surface; (3) apply secondary antibody that also
binds specifically to the antigen; (4) apply enzyme linked secondary antibody that binds to the
secondary antibody; (5) apply a chemical that is converted by the linked enzyme into a colored
product. The concentration of the colored product is measured by a spectrophotometer and the
intensity of color is proportional to the concentration of bound antigen. ELISA test is very
convenient, can detect antigens with low or unknown concentrations, and has high specificity
since the capture antibody only captures the specific antigen. In addition, it does not require
radioactive substances and can be used in a wide variety of tests. However, ELISA test has some
major drawbacks: the secondary antibody must recognize the primary antibody; negative
controls may indicate positive results if blocking solution is ineffective, because secondary
antibody or antigen can bind to open sites as well; enzyme/substrate reaction is short term so that
microwells must be read as soon as possible.

4

Figure 1.1 Scheme of a sandwich ELISA test.

1.2.3 DNA microarray
A DNA microarray is a collection of microscopic DNA spots attached to a solid surface.
It consists of an arrayed series of microscopic spots of DNA oligonucleotides, and each spot
contains picomoles (10−12 moles) of a specific DNA sequence known as probes. A short section
of a gene or other DNA segments is used as probes to hybridize a targeted complementary DNA
or RNA sample under high-stringency conditions. Probe-target hybridization is usually detected
and quantified by fluorescence-based detection of fluorescently labeled targets to determine
relative abundance of nucleic acid sequences. Since a DNA microarray contains thousands of
probes, one experiment can accomplish many genetic tests at the same time. Therefore using
DNA microarrays have dramatically accelerated many types of investigation. DNA microarrays
can be used to express large numbers of genes simultaneously, find new biomarkers, and detect
DNA, RNA, proteins, cancer biomarkers, etc.13-15 Although the DNA microarray is very useful
in medical diagnostics and biodetection, it have some limitations: it is relatively expensive; it is
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not readily or easily reproducible; the data quantity often overwhelms the users and make the
analysis and interpretation is difficult; for this fluorescence based detections, the dyes molecules
tend to photo-bleach after certain time, which decreases the lifetime or measurement time.
1.3 Nanomaterials for cancer biomarker detection
The advent of nanostructured materials and micro-fabricated devices enables the
construction of highly sensitive, ultra-small, and portable sensing devices with multiple detection
capability. As sizes of the sensing elements in these devices are reduced to nanometer, unique
optical, electrical or electrochemical, and magnetic properties of the nanomaterials allow them to
be used for more selective, sensitive and precise detection of biomarkers. Nanomaterials have
become an effective tool for biodetection due to the following reasons: (1) their small size allows
intimate contact with biomolecules, (2) surface properties can be modified to efficiently capture
target molecules, (3) detection signal can be amplified by physical means; (4) size, surface,
composition and morphology of the nanoparticles can be tuned precisely.
1.3.1 Biosensing using nanoparticles
The presence of biomarkers in the sample will cause nanoparticles to be immobilized
onto a substrate or combine with another nanoparticle; a physical signal transduction method can
be used to derive the existence and concentration of target biomarkers. The nanoparticle based
biosensing can be performed in three-stranded configuration for DNA detection or sandwiched
configuration for protein detection (Figure 1.2). For DNA detection using three-stranded
configuration, the surface of nanoparticles is first modified with probe DNA that can bind to one
end of target DNA, and a substrate is modified with capture DNA that can bind to the other end
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of the target DNA. The solid substrate is immersed into the solution containing target DNA, after
hybridization, the substrate is washed and then immersed into a solution containing probe DNA
functionalized nanoparticles. The target DNA will immobilize nanoparticles onto the substrate
through DNA hybridization. The immobilized nanoparticles are then readout by using a physical
method to reflect the existence and concentration of the target DNA.

Nanoparticles

nanoparticles

Probe DNA

antigen

Target DNA
Capture DNA

antibody

Figure 1.2 Nanoparticles based three-stranded (left) and sandwiched (right) configuration for
DNA and protein detection, respectively.

Similarly, for protein detection using a sandwiched configuration, a substrate is modified
with primary antibody that can capture the target antigen, and the surface of nanoparticles is
modified with secondary antibody that can bind to the target antigen. After immersing into a
solution containing the target antigen, the substrate is then incubated with secondary antibody
functionalized nanoparticles and the nanoparticles are immobilized onto the substrate surface by
antibody-antigen-antibody interaction. The signal from the immobilized nanoparticles measured
by a physical method will indicate the existence and concentration of the target antigen.
1.3.2 Surface modification
A variety of strategies have been used to modify surfaces of nanoparticles or substrates.
The most widely used sensing surfaces are gold, glass, indium tin oxide (ITO), carbon and
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silicon. Gold thin films or nanoparticles can be modified with self-assembled monolayer of
alkanethiols. Thiol molecules can form gold-sulfur complex bond, and form highly ordered
monolayer on gold surfaces through self-assembly. Different terminated functional groups can be
used to conjugate biological recognition elements. For example, carboxyl groups are used to
immobilize antibody; esters for amine couplings; biotin coupling can be used to bind streptavidin
and further biotin functionalized biomolecules. Silanes with methoxy or ethoxy residues have
been used to modify glass or silicon surfaces by reacting with surface hydroxyls, and the other
end of silane molecule provides a reactive residue to bind to biomolecules. For example, in order
to immobilize antibody on glass surface, 3-amino-propyltrimethoxysilane (APTES) can be used
to ammonize the substrate, which is followed by activating surface with a bifunctional
cross-linker-disuccinimidyl suberate (DSS), and the other end of the cross-linker will be
conjugated to the free amine group of antibody (Figure 1.3).

Figure 1.3 Immobilizing antibody on a glass substrate by surface chemistry.

1.3.3 Fluorescence nanoparticles
Semiconductor nanoparticles made by colloid chemistry methods have shown fluorescent
emissions in visible light range, and the wavelength can be controlled by changing composition
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and size of nanoparticles. Semiconductor nanoparticles have been widely used in biological
imaging and bioanalyses including cell staining, cell surface receptor targeting, DNA, protein
and biomarkers detection.16-20 The readout from fluorescent nanoparticles can be performed with
a spectrophotometer to indicate the presence and concentration of target molecules. The
detection can be done with three-stranded and sandwiched configurations by monitoring
intensity of fluorescence light. Compared to traditional dyes that tend to photobleach,
semiconductor nanoparticles exhibit important advantages in terms of high luminescence and
photostablility.21 Semiconductor nanoparticles can improve detection sensitivity due to their
large surface to volume ratio. However, semiconductor nanoparticles suffer from a serious
limitation for multiplexed detection. According to Rayleigh criterion on spectral resolution, if the
distance between two peaks is shorter than their half width at maximal height, these two peaks
will not be resolved from each other (Figure 1.4). Normally, complex peak resolving algorithm
will have to be used. In the case of semiconductor nanoparticles, although individually, the
emission peaks can be controlled to be sharp by precisely controlling their diameters, once
nanoparticles of different colors are mixed, it will be difficult to resolve the spectrum. The peak
width at half height of normal fluorescence semiconductor nanoparticles is about 150 nm. In the
visible range from 400 to 900 nm, the maximum number of different nanoparticles that can be
resolved would be about 4-5, meaning the detection multiplicity would be very low.
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Figure 1.4 Rayleigh criterion.

1.3.4 Plasmonic nanoparticles
Surface plasmon resonance (SPR) biosensors, based on metallic nanoparticles, can be
used for DNA, protein and cancer biomarker detection.22-26 Surface plasmons are surface
electromagnetic waves that propagate in a direction parallel to the metal/dielectric interface.
Since the wave excited by light propagates on the boundary of the metal and the external
medium (e.g., air or water), these oscillations are very sensitive to any changes that take place on
the boundary, such as the adsorption of molecules to the boundary. For metallic nanoparticles,
the wave is very sensitive to the changes in shape and size of the nanoparticles as well as the
interparticle distance. These phenomenon form the basis of many standard tools for detecting the
adsorption of molecules onto the surface of metallic nanoparticles and for determining the
concentration of biomolecules through color changes induced by biological events or through
surface plasmon resonance peak shift of the nanoparticles.
The SPR spectral profile and peak wavelength λmax depend on the composition, size,
shape and local dielectric environment of the nanoparticles. The simplest theoretical approach
for modeling the optical properties of nanoparticles is the Mie theory, which is described as27
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E(λ) is the extinction (sum of absorption and scattering), NA is the density of
nanoparticles, a is the radius of the metallic nanosphere, εm is the dielectric constant of the
medium surrounding the metallic nanosphere, λ is the wavelength of the absorbing radiation, εi is
the imaginary portion of the metallic nanoparticle’s dielectric function, εr is the real portion of
the metallic nanoparticle's dielectric function, and χ is the term that describes the aspect ratio of
the nanoparticle (equal to 2 for a sphere). From the equation, it is clear that the SPR spectrum of
an isolated metallic nanosphere embedded in an external dielectric medium will depend on the
nanoparticle radius a, composition of the nanoparticles (εi and εr), and the environment's
dielectric constant (εm). The peak wavelength λmax occurs when the denominator of the term in
brackets approaches zero. This occurs at the wavelength where εi is small and εr=- χ εm. For
spherical nanoparticles, χ is equal to 2 and the equation is modified such that the peak
wavelength λmax occurs when εr=-2εm. In order to study the surface plasmon response of
nanoparticles due to changes in their dielectric environment, a technique that produces
nanoparticles with uniform size and shape is required. However, achieving this is challenging for
most scientific researchers. In addition to uniformity, it is also important to develop surface
plasmon resonance sensors that are stable against solvent annealing. To overcome theses issues,
nanoparticles can be pretreated in water or organic solvents. However, this will make the
detection process time-consuming.
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1.3.5 Electrochemical detection using nanostructured electrodes
Electrochemical biosensors have been used to detect nucleic acids, proteins, antibodies,
cells or cancer biomarkers in body fluids, food samples, cell cultures and environmental samples
due to their smart size and quick and dependable response compared to the conventional
biodetection systems.28-30 The detection mechanism is based on that the sensors convert the
redox reactions occurring at electrode surfaces into electronic signals, which can be processed by
a processing system and readout through an interface to the human operator. Nanostructured
electrodes have been widely used to increase the electro-active surface area and enhance electron
transfer due to their high surface-to-volume ratio, good biocompatibility, conductivity and
catalytic properties. The increase in electro-active surface area allows for lower detection limit
and higher sensitivity to analytes. Typically, nanostructured electrodes can be made by attaching
metallic nanoparticles, or nanowire or nanotube arrays.31-33
Although nanostructured electrode surface can be made by the surface modification,
capping reagents, cross-linker molecules, and other binder materials (e.g., polymer) will more or
less affect the electron-transfer reactions. In order to avoid these issues, an alternative way
should be developed to attach the nanoparticles onto the electrode surfaces without using a linker
molecule or polymer to magnify the effective electrochemical responses and suppress the
unfavorable effects. Various metallic nanoparticles can be attached to the electrode surfaces
without using a linker molecule for electrochemical analysis by the seed-mediated growth or
electrochemical deposition method. The attached nanoparticles can increase the electro-active
surface area and adsorb more bridging molecules. Thus the electron transfer process is
accelerated and the signal can be measured by the electrical equipment when the redox-activate
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analyte bind with the bridging molecules. Although a low limit of detection can be obtained by
this technique, the nanoparticles attached on the electrode surfaces are not very robust and the
modified surfaces are difficult to be recovered once damaged.
Nanowires or nanotubes modified electrodes have been widely used in electrochemical
biosensors for biological detection because of their high surface-to-volume ratio and good
electron transport properties. Highly dense nanowires or nanotubes standing on the electrode
surface can be synthesized efficiently by using a template through self-assembling process,
electrochemical deposition, molecular beam epitaxy or electron beam evaporation.34,

35

By

controlling the experimental conditions (e.g., the template), the structure of the nanowires or
nanotubes can be adjusted conveniently and their properties can be tuned effectively. It should be
noticed that the wire or tube diameter, wire surface condition, crystal structure and its quality,
chemical composition and crystallographic orientation along the wire axis are important
parameters that influence the conductance of the nanowires. When the analytes are adsorbed onto
the surface of the nanowires or nanotubes, which have been modified by a bridging molecule
(e.g., enzyme), a significant electrical response is observed because of the redox reaction that
took place on the surfaces. Although high sensitivity can be achieved by using the nanowires or
nanotubes modified electrodes, the uniformity and the growth orientation still limit the wide use
of electrochemical biosensors. Furthermore, after the detection process, the nanowires or
nanotubes surface may form an oxide layer, which is not recoverable.
1.3.6 Magnetic nanoparticle for biodetection
Biosensing strategies based on magnetic nanoparticles have received considerable
attention because they offer unique advantages over other techniques. For example, magnetic
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nanoparticles are inexpensive to produce, physically and chemically stable, biocompatible, and
environmentally safe. In addition, biological samples exhibit virtually no magnetic background,
and thus highly sensitive measurements can be performed in turbid or otherwise visually
obscured samples without any further processing. To date, numerous methods using magnetic
labels have been developed to detect biomolecules. These techniques use magnetometers, such as
superconducting quantum interference device sensors, giant magnetoresistive (GMR) sensors,
and Hall sensors, to directly detect magnetic nanoparticles and derive the concentration of the
target biomolecules.36-38 In particular, GMR sensors have triggered scientific researchers’ interest
because it have shown great potentials for the detection of DNA, proteins, microorganisms,
cancer biomarkers, etc.

Figure 1.5 Schematic description of the giant magnetoresistance effect. Blue curve:
magnetization of the multilayer versus applied magnetic field. Red curve: electrical resistance of
the multilayer. The insets indicate the magnetic configuration of the multilayer in zero field and
at positive and negative saturation fields.

GMR sensors are sensitive, can be easily integrated with electronics and microfluids, and
can generate fully electronic signals. Giant magnetoresistance is a quantum mechanical
magnetoresistance effect observed in thin film structures composed of alternating ferromagnetic
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and non magnetic layers. Depending on whether the magnetization of adjacent ferromagnetic
layers is in parallel or in antiparallel alignment, the electrical resistance of the thin film exhibits a
significant difference. Namely, the overall resistance is relatively low for parallel alignment and
relatively high for antiparallel alignment (Figure 1.5). GMR sensors are based on the binding of
magnetic particles to a sensor surface where the magnetic fields of the particles alter the
magnetic field of the sensor which results in changes in electrical current within the sensor.
There are two mechanisms through which magnetic particles bind to the sensor surface: (i) direct
labeling and (ii) indirect labeling (a sandwich type binding). Normally, magnetic probes bind to
functionalized surfaces in direct labeling by using streptavidin-biotin interaction or
complementary DNA sequence recognition (Figure 1.6). While indirect labeling uses a sandwich
configuration. For example, primary antibodies that bind to the target protein are immobilized on
the surface. After treatment of the surface with a sample solution containing the target proteins,
biotinylated second antibodies are added to the system. Finally, streptavidin coated magnetic
particles are applied for tagging the biotinylated antibodies. This magnetic biodetection system is
based on detecting fringing field of captured magnetic nanoparticle labels for bimolecular
detection. The significant advantage of GMR sensors is their high sensitivity to small changes in
the magnetic fields. However, for all their advantages, the GMR sensors have one serious
drawback because their manufacture requires a complicated technology. Besides, low reading
signals arising at re-magnetization of magnetic nanoparticles is also one of the main problems at
the design of GMR biosensors.
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Figure 1.6 Principle of biosensor using magnetic and magnetic nanotags. The resistance of the
sensor is altered by the magnetic field generated from attached nanoparticles.

1.3.7 Nanowire and nanotube for biodetection
One dimensional semiconductor nanomaterials, in particular silicon nanowires and
carbon nanotubes have been used in biosensing. These nanomaterials have extremely high
surface-to-volume ratio and sensitivity of the carrier mobility to the variations in the electric field
(charge density) at their surface, make them ideal for field effect transistors (FETs) based
biosensors for label-free, sensitive and real-time detection of biological objects.39 The sensing
mechanism of silicon nanowire or carbon nanotube FETs is based on the surface change in
charge density that induces an electric field change at the silicon nanowire or carbon nanotube
surface after some biological events have occurred, such as analyte adsorption, DNA
hybridization or antibody-antigen binding. Theoretical calculations suggest that nanowire sensors
have much shorter response time and this will make the real-time detection of biological
molecules possible. In the real-time detection process, the conductance of an individual
single-walled carbon nanotube (SWCNT), or a network of SWCNTs, during the introduction of
the analyte solution, is monitored and the resistance of the device is found to be either directly or
inversely proportional to the concentration of the analyte.
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However, nanotube/nanowire based biosensors are difficult to produce. Normally,
nanowire or nanotubes are made first by chemical vapor deposition method. The as made tangled
bundles have to be separated and purified, and cut into appropriate lengths. Subsequently, they
have to be deposited across electrodes to form stable connections. Although many techniques
have been developed to manipulate nanowires using electrical field, microfluid, atomic force
microscopy or dielectrophoresis, these methods have low yield, and take a lot of time.40-43
Furthermore, even if nanowires could be aligned between electrodes, each nanowire should be
modified with different species, which requires site-specific patterning tools, such as dip-pen
nanolithography (DPN). After modification, each wire should be electrically connected out, and
the readout circuit could be very complex if multiple species are to be detected.
1.3.8 Nano-mechanical cantilever for biosensing
Microcantilevers have been used to detect DNA and RNA, protein, glucose, and cardiac
biomarkers by detecting changes in nanomechanical properties (bending or vibrating) induced by
biological interactions.44-49 The microcantilevers are normally made of silicon or silicon nitride
using microfabrication techniques, and the normal dimensions of a microcantilever are
20×40×0.6 μm3. One side of cantilever is coated with thin films of gold to reflect laser beam,
which is then directed into a position sensitive detector. The bending or vibration of cantilever
can be monitored using laser optical levers with high precision. Cantilever bending can also be
monitored using other techniques such as piezoelectric sensors, tunneling current and optical
interferometry. Microcantilevers can be operated in two modes to detect biomolecules static
mode and dynamic mode, where either the surface stress or the resonance frequency of the
cantilever is measured (Figure 1.7).
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Figure 1.7 Cantilever sensor modes of operation: (A) dynamic mode and (B) static mode

In the dynamic mode, cantilevers are excited close to their resonance frequency typically
in the kHz or even MHz range, and can be treated as an ideal oscillator with a basic resonance
frequency of

f 

1
2

kspring

(2)

m

where kspring is the spring constant and m* is an effective mass (taking into account the cantilever
geometry and mass distribution along the cantilever). The attachment of target biomolecules on
microcantilever leads to mass change, which in turn leads to frequency shift into the low
frequency end. The sensitivity of mass detection depends strongly on the geometry of the
microcantilevers. By engineering the geometry of the cantilever, single molecular mass change
can also be detected using cantilever with high intrinsic frequency (stiffness). However, dynamic
mode cannot be used in solution due to viscous damping, which broadens the resonant peak and
reduces sensitivity of mass resolution. A recent and interesting development avoids damping by
combining microfluid with microcantilever and delivering liquid in hollow cantilevers. This
eliminates viscous damping and maintains mass sensitivity of cantilever sensors. But the cost of
fabrication is too high due to high failure rate of production.
In the static mode, the asymmetric binding of target molecules on one side of cantilever
will produce intermolecular stress and change surface stress of the cantilever leading to a bend of
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the cantilever. Normally, the gold reflection film on cantilever is modified through gold-thiol
chemistry, and the other side (silicon or silicon nitride) is coated with polymer to reduce
non-specific binding. The surface stresses produced in cantilever can be described using
Stoney’s formula:

 

Et 3
z
3(1  ) L2

(3)

where Δσ is the difference in surface stress between the bottom and top surfaces of a cantilever,
E is elasticity modulus, ν is the Poisson ratio (which is about 0.3 for silicon), t is the cantilever
thickness, L is the cantilever length and Δz is the cantilever deflection. The cantilevers operating
in static mode can be used to detect gas molecules, metal ions and biomolecules. But,
asymmetric surface modification of cantilever is not easy to do; surface stress is extremely
sensitive to uniformity of molecular coating, which can lead to sensitivity variation; the thermal
energy from exothermic or endothermic surface reactions creates a resultant temperature change
on the cantilever, resulting in unwanted heat induced bending, thereby, introducing erroneous
results.
Most importantly, although multiple microcantilevers can be generated to detect multiple
biomarkers at the same time, the readout electronics will be very complex and hard to achieve.
Although multiple micro-mirrors have been designed to overcome this issue, it is found that each
cantilever will have different response due to thickness variation of microcantilevers.
Meanwhile, the micromirrors require a high resolution charge-coupled device to continuously
monitor the shift of reflected laser beams, and are expensive to build and use.
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1.4 Need for multiple biomarkers of cancer
Despite significant progress in the investigation of cancer biomarkers, some people are
over diagnosed with indolent cancer while others die from aggressive diseases that are diagnosed
too late. Although several markers have reasonable operating characteristics, no individual
marker is ideal. Because cancer is a polygenic disease, it is possible that a combination of
biomarkers may provide better predictive value. Future research is warranted for the
identification of new biomarkers, as well as novel informatics approaches to a combination of
multiple biomarkers to maximize the information from currently available data.
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CHAPTER 2: THERMAL DETECTION OF MULTIPLE DNA
BIOMARKERS CONTAINED IN COMPLEX FLUIDS USING PHASE
CHANGE NANOPARTICLES

2.1 Introduction
Current in vitro cancer detections and diagnosis are strongly dependent on biopsies,
where tissue samples are removed from patients for analysis. Although effective in preparing
samples, such invasive methods are not suitable for monitoring cancer development and
treatment effects. Some cancer cells can exfoliate from the original tumors and enter the
circulations, and provide an alternative way for the non-invasive or less-invasive detection and
diagnosis. It is challenging, however, to detect circulating tumor cells because of their extremely
low concentration (1-10 cancer cells in 1 ml blood).50-52 As a result of fragmentation of the
chromatin from dying tumor cells, tumor cells can release molecular biomarkers (i.e., DNAs and
proteins) into the circulation. The circulating DNAs reflect the molecular level changes of
tumors such as methylation, microsatellite instability and point mutation, and can be used for
highly sensitive and less-invasive cancer detections.53-55 In addition to less invasiveness,
detecting molecular biomarkers in body fluid or cell lysate offers many benefits such as minimal
sample preparation, more retention of target molecules, low cost, and short analysis time.56-62
Although polymerase chain reaction (PCR) and enzyme-linked immunosorbent assay
(ELISA) have shown extremely high sensitivities for biomarker detection, these techniques
cannot always be used to complex fluids such as cell lysate.63,
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64

The application of such

techniques is limited in the point-of-care due to sample preparation, equipment maintenance, and
needs for skilled personnel.65 A variety of nanoparticles with unique optical, electric, magnetic or
electrochemical property have been used for in vitro detections of biomarkers.66-72 By converting
biological recognition events into physical signals that can be amplified, nanoparticle based
methods achieve high sensitivity at the pico-mole/liter level owing to intimate contact with
biomarkers in solution. However, these methods (except magnetic nanoparticle) require
extensive sample preparation effort prior to detection. Otherwise, errors associated with sample
preparation could be large, which will compromise their high sensitivities. For example, colored
species in body fluid (i.e., red blood cell) have to be removed for optical detection; pH or salt
concentration may affect the electric or electrochemical signals of nanoparticles; although
magnetic signals are immune to impurities contained in samples, the signals cannot be amplified
readily, and the detection sensitivity is not as high as others.73-75
The multistage growth of cancers is characterized by gradual accumulations of molecular
genetic abnormalities associated with a range of dynamic processes such as cell cycles,
senescence, apoptosis, cellular repair, differentiation and migration.76 The diversity of cancers,
combined with the complexity of each biological system, makes it difficult to detect molecular
biomarker in biofluids.77 At the early stages, biomarkers are at low concentrations and cannot be
detected readily. The medical decision based on single biomarker has a high probability of false
positive and false negative.78 Thus, single biomarkers alone are not effective for accurate
diagnosis. One effective way to enhance the accuracy of diagnosis is to detect multiple
biomarkers from the same sample.79 In one example, 3 to 5 biomarkers can provide more than
0.94 accuracy compared with single biomarkers.80 Since the amount of sample obtained from a

22

patient is limited, and the quantity of biomarkers is very low, it is desirable to detect multiple
cancer biomarkers from one sample using a highly sensitive and multiplexed method.
We have developed a method to detect short single stranded oligonucleotides (ssDNAs)
in bodily fluids using solid-liquid phase changes of nanoparticles (Figure 2.1). The signal
transduction is based on the thermal properties of nanoparticles by utilizing a well-known, but
unexplored phenomenon, namely, the temperature of a bulk solid will not rise above its melting
temperature until the solid becomes liquid completely. In the thermal test, the nanoparticle
probes will melt at a narrow temperature range. The position of sharp melting peak and related
heat flow are dependent on the nature of the phase change nanoparticles, and the amount of
biomarkers in solution, and thus can be used for the qualitative and quantitative biomarker
detection. A combination of nanoparticles with different melting temperatures can be used to
detect multiple biomarkers with a high level of multiplicity. Since the melting points of
nanoparticles can be designed above the melting temperatures of species contained in bodily
fluids, the thermal nanoparticles can be used to directly detect molecular biomarkers in bodily
fluids. The detection signals are readout using a power compensation differential scanning
calorimetry, in which the heat flow added into a sample to keep its temperature the same as a
reference is plotted as function of temperature. The thermal signal transduction mechanism has
no macroscopic analog, but brings high sensitivity and multiplicity, as well as sample
preparation benefits to the area of biomarker detections. Compared to normal micro-calorimetry
of biological interactions, this approach has higher sensitivity, multiplicity, and specificity owing
to the existence of thermal nanoparticles.
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Figure 2.1 Detecting multiple DNA biomarkers using phase change nanoparticles.

2.2 Experimental and methods
2.2.1 Synthesis of nanoparticles
The phase change nanoparticles of low melting temperature metals and alloys are
prepared by the thermal decompositions of organometallic precursors. The precursors, such as
indium acetate, lead acetate and tin acetate are obtained from Aldrich and used without
purification. The precursors or their mixtures at desired molar ratio, and polyvinylpyrrolidone
(with molecular weight of 11000) are dissolved in ethylene glycol (Aldrich). The mixture is
refluxed at 200°C to decompose precursors under nitrogen protection. After reacting for 20
minutes, the reaction is quenched by pouring the mixture in 200 ml ethanol pre-cooled at 0°C.
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The as-prepared nanoparticles are centrifuged at 3000 rpm to remove un-reacted precursors, and
washed by absolute ethanol for three times. A Zeiss Ultra 55 scanning electron microscope
(SEM) at accelerating voltage of 10 kV is used to image nanoparticles dispersed from suspension
onto a conductive silicon surface. The compositions of nanoparticles are analyzed by an energy
dispersive X-ray (EDX) detector. A JEOL 1011 transmission electron microscope (TEM)
operated at 100 kV is used to image the nanoparticles.
2.2.2 Surface modifications
The synthetic short oligonucleotides are obtained from Integrated DNA Technologies
(IDT). The probe ssDNA is 5'-TTACAATAATCCATTATTATTA/3ThioMC3-D-3'; the target
ssDNA is 5'-GGATTATTGTAAACACAGCAACCACAT-3'; and the capture ssDNA is
5'-/5AmMC6/-ATTATTATTATGTGGTTGCTGTGT-3'. The sequences of oligonucleotides are
designed to be non-specific for proof-of-principle, and are not representative of any biomarkers.
Figure 2.2 shows the procedure of modifying the surfaces of phase change nanoparticles, and
DNA hybridization. The nanoparticles are modified with amine-terminated monolayers by
adding 3-aminopropyltriethoxy-silane (APTES) into the suspension of nanoparticles in toluene.
After reacting for 3 hrs at the room temperature, extra silane is removed by centrifugation, and
nanoparticles are re-suspended in dimethyl sulfoxide (DMSO) that contains N-succinimidyl
(4-iodoacetyl) aminobenzoate (SIAB) and incubated for 20 min to complete the reaction. The
disulfide-containing probe ssDNA is reduced to 3’ thiolated probe ssDNA by incubating with tris
(2-carboxyethyl) phosphine (TCEP) at pH 4.5 in tris (hydroxymethyl)-aminomethane (TE)
buffer at 37°C for 3 hrs. After removing excess SIAB by centrifugation, the nanoparticles are
incubated with the 3’ thiolated probe ssDNA in a phosphate buffer solution (PBS, pH 8.0) at the
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room temperature. The aluminum surface is modified by APTES in vapor phase, where the
surface is kept in a vial that contains 0.1 ml of APTES and heated for 3 hrs at 100ºC. After
washing the surface with DMSO, the aluminum surface is immersed into a DMSO solution of
disuccinimidyl suberate (DSS) for 1 hr. The surface is washed with PBS and incubated with
capture ssDNA in PBS solution (pH 8.0) for 3 hrs. The hybridization of target ssDNA with
capture ssDNA is carried out by immersing the modified aluminum surface in a target ssDNA
solution of TE buffer (pH 7.5, 1M NaCl). After reacting for 3 hrs at 37ºC, unbounded capture
ssDNAs are removed by washing with PBS.

Figure 2.2 Detailed procedures of surface modification and DNA hybridization.

2.2.3 Cell lysate preparation
The MDA-MB-231 human breast cancer cells obtained from American Type Culture
Collection (ATCC, Manassas, VA) are used. The cells are grown to confluence in T-75 tissue
culture flasks using a protocol suggested by ATCC. Then the culture medium is removed and
the cells are washed with the PBS at pH 7.5. The cells are lysed in a 3 ml flask with lysis buffer
for 15 min at 4°C with gentle rocking, where the lysis buffer is composed of 10 mM Tris-HCl at
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pH 7.5, 100 mM NaCl, 1 mM EDTA, and 1% Triton X-100. The cell lysate is collected and
centrifuged at 12,000 rpm for 10 min at 4°C to remove debris. The supernatant of the cell lysate
is collected and stored in small aliquots at -20°C until use. The total protein concentration of cell
lysate is determined to be 1.1 mg/ml using the DC Protein Assay reagent (Bio-Rad Laboratories,
Hercules, CA). Bovine serum albumin is used as the standard.
2.2.4 DSC measurements
A PerkinElmer DSC (DSC 7) is used to measure the melting temperatures and fusion
enthalpies of nanoparticles. For nanoparticle characterization, ~10 mg of nanoparticles is sealed
inside an aluminum pan and the DSC test is carried out from 50 to 250°C at a ramp rate of 10°C
per minute. An empty aluminum pan is used as reference to measure the difference in the heat
flows of sample and reference. Both aluminum pans are washed for several times by ethanol and
acetone. The detection sensitivity of the equipment is calibrated by measuring the fusion
enthalpy of a known amount of bulk material (i.e., indium). For DNA detections, we have
modified the aluminum surface with a monolayer of amine terminated molecules by APTES,
because the aluminum surface is covered with a thin layer of native oxide after exposing to
ambient atmosphere. The patterned immobilizations of fluorescence labeled bovine serum
albumin (BSA) on the amine monolayer through covalent bonds confirm the modifications of
aluminum surfaces by APTES. In order to capture the target ssDNA from samples, DSS is used
to the immobilize capture ssDNA on the amine terminated aluminum surfaces.
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2.3 Results and discussion
2.3.1 Phase change nanoparticles
The structures, morphologies, and thermophysical properties of indium, and lead-tin alloy
nanoparticles have been confirmed by the normal characterization methods. Figure 2.3A and
2.3B show the TEM images of indium and lead-tin nanoparticles, respectively. The DSC curves
confirm the solid-liquid phase changes of indium and lead-tin nanoparticles (Figure 2.3C and
2.3D), which shows the melting temperatures of indium and lead-tin nanoparticles are 156 and
183°C, respectively. Although it has been found that nanoparticles with diameter smaller than
the critical diameter (~40 nm) melt at lower temperatures,81, 82 the nanoparticles prepared here
have similar melting points as bulk materials due to their large diameters. In order to modify the
surfaces, the nanoparticles of indium and lead-tin alloy are dried and baked at 100°C in an oven
for 1 hr. This procedure will oxidize the surfaces of low melting nanoparticles. These
nanoparticles are immersed into 5% APTES in toluene for 3 hrs. After removing extra APTES
by centrifuging, nanoparticles are washed by toluene and DMSO.
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Figure 2.3 TEM images of indium (A) and lead-tin alloy nanoparticles (B); DSC curves of
indium (C) and lead-tin alloy nanoparticles (D).

2.3.2 DNA detections in buffers
Target ssDNAs dissolved in phosphate buffers at pH 8.0 are studied as standard samples
for DNA detection. The probe ssDNA modified nanoparticles, and capture ssDNA modified
aluminum surface are added into the buffer solution for hybridization. After hybridizing for 3
hrs, the aluminum surface is taken out of the buffer solution, washed by phosphate buffer and
tested by DSC. The standard samples contain a variety of concentrations of target ssDNAs from
8 nM to 0.8 fM in 1M NaCl and TE buffer. The melting peaks of phase change nanoparticles
immobilized through DNA double helix are used for the qualitative and quantitative detections.
Figure 2.4A shows the melting peaks of lead-tin alloy nanoparticles, where the curves from the
top to bottom correspond to the concentrations of target ssDNA from 8 nM to 0.8 fM. The areas
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of melting peaks can be derived by integrating heat flow over the melting range, and are
proportional to the masses of nanoparticles or the mole numbers of target ssDNA. Figure 2.4B
shows the relation between the melting peak area and the target ssDNA concentration, where a
linear relation exists between the target ssDNA concentration and the peak area, and the lowest
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Figure 2.4 DSC curves of lead-tin alloy nanoparticles captured by target ssDNA at different
concentrations in buffer solutions (A); the relation between target ssDNA concentrations and
heat flows of lead-tin nanoparticles (B).

In order to test the possibility of different type of phase change nanoparticles, similarly,
another type of phase change nanoparticles, indium nanoparticles, are used to detect target
ssDNAs in buffers. The experiment results show that it can also be used for the detection of
ssDNA in buffers. Figure 2.5A shows the DSC curves of indium nanoparticles collected at
different target ssDNA concentrations. Figure 2.5B shows the relation between the measured
peak area and the concentration of ssDNAs, where a linear relation exists between the target
ssDNA concentration and the peak area, and the lowest detectable concentration is determined to
be 80 pM.

30

-0.3

A

80nM
8nM
0.8nM
80pM

0.4
0.2
0.0
152

154

156

158

Temperature (C)

Log (Peak area)

Heat flow(mW)

0.6

160

B

-0.6
-0.9
-1.2
-1.5

-10

-9

-8

Log(Concentration)

-7

Figure 2.5 DSC curves of indium nanoparticles captured by target ssDNA at different
concentrations in buffer solutions (A); the relation between target ssDNA concentrations and
melting peak areas of indium nanoparticles (B).

2.3.3 DNA detections in complex fluids
Cell lysate and milk are two biological samples that contain abundant proteins and
DNAs. The melting temperature of the phase change nanoparticles made in this experiment is
higher than the coexisting species in cell lysate or milk, thus the thermal readout will not be
interfered by species in body fluids. But, the DNA hybridization can be affected by abundant
proteins or DNAs. Target ssDNAs are added to cell lysate or milk at certain concentrations, and
detected using the same method described above. The pH values and ion concentrations of cell
lysate are adjusted to be 10 mM Tris-HCl at pH 7.5, 100 mM NaCl, and 1 mM EDTA. Figure
2.6A shows the melting peaks of indium nanoparticles after detecting the target ssDNAs in cell
lysate, where the curve from the top to bottom are collected at the concentrations of target
ssDNA ranging from 8 nM to 80 pM. Although the temperature range is from 50 to 200ºC, the
most parts of curves do not show any heat absorbing behaviors, thus only the thermal behavior in
the range from 144 to 168ºC is displayed. Figure 2.6B shows the relation between the peak area
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and the concentration of target ssDNA, from which the lowest detectable concentration is
determined to be 80 pM. There exists a linear relation between target ssDNA concentrations and
heat flows at relatively higher concentrations.
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Figure 2.6 DSC curves of indium nanoparticles captured by target ssDNA at different
concentrations in cell lysate (A); the relation between the target ssDNA concentrationand peak
areas of indium nanoparticles (B).

Furthermore, the target ssDNA can also be detected in milk. The target ssDNA is added
in fresh milk to make samples that are not transparent and detected by the same method. The pH
values and ion concentrations of milk are adjusted to10 mM Tris-HCl at pH 7.5, 100 mM NaCl,
and 1 mM EDTA. Figure 2.7A shows the DSC curves of lead-tin nanoparticles that are collected
at different concentrations of target ssDNAs, where the melting peaks are attributed to
immobilized lead-tin nanoparticles. Figure 2.7B shows the relation between the measured peak
area and the concentration of target ssDNA after detecting target ssDNAs from milk.
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Figure 2.7 DSC curves of lead-tin nanoparticles captured by target ssDNA at different
concentration in milk (A); the relations between the target ssDNA concentration and peak areas
of lead-tin nanoparticles (B).

2.3.4 Comparison of DNA detections in buffers and complex fluids
Compared to buffer solutions with clearly defined composition, cell lysate and milk
contain abundant proteins; meanwhile, cell lysate could also contain un-removed
double-stranded DNA due to disintegration of the nuclear membrane. The proteins or DNAs can
affect the detections of the target ssDNAs through either specific interaction or non-specific
adsorption. We have compared the peak areas measured at different concentrations of the target
ssDNAs in buffer, cell lysate, and milk. The similar level in response of heat flow means that
target ssDNA has been detected. However, there are some differences in the magnitudes of peak
areas: peak areas derived from the buffer solutions is similar to those from milk, suggesting that
the abundant proteins (1.1 mg/ml) do not affect the hybridization of the target ssDNA very
much. Instead, the heat flows measured from the cell lysate are about 20% higher than that from
buffer and milk. In the cell lysis process, we have used Triton X-100 as the detergent agent to
break cell membrane, which might also break the nucleus membrane and release some DNAs
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into the cell lysate. It is possible some of the released DNA with sticky ends may interact with
the capture ssDNA and probe ssDNA, causing the increased heat flows.
2.3.5 Detecting multiple DNA biomarkers
The sharp and discrete melting peaks of nanoparticles allow the establishment of a
one-to-one correspondence between the melting peaks of nanoparticles and biomarkers, thus the
method has high multiplicity. We have used this method to detect two different target ssDNAs
simultaneously by modifying capture and probe ssDNAs on aluminum surfaces and two types of
nanoparticles (i.e., indium and lead-tin alloy). The sequence of the first target ssDNA (ssDNA1)
used to modify indium nanoparticles is the same as described above, and the sequence of the
second

ssDNA

(ssDNA2)

to

modify

lead-tin

nanoparticles

is

5'-CTTAATGGTGCTTGTACTAAGGTCGCC-3'. The capture and probe ssDNAs for the
second target have the complementary sequences to each end of the second target. We have
mixed the two capture ssDNAs at 1:1 molar ratio and immobilized them on one aluminum pan.
Meanwhile, two target ssDNAs are dispersed in PBS at pH of 7.5 and 1M NaCl. The probe
ssDNA modified indium and lead-tin nanoparticles, and the capture ssDNA modified aluminum
surfaces are immersed into the PBS that contains two types of target ssDNAs for 3 hrs. After
DNA hybridization, the aluminum surface is washed with a phosphate buffer and tested by DSC.
Figure 2.8A shows the melting peaks of indium, and alloy nanoparticles covalently bonded on
aluminum surfaces, thus confirming the existence of two types of target ssDNA in the solution.

34

2.3.6 Nanoparticle dependent sensitivity
The detection sensitivity is dependent on the mass and the latent heat of fusion of
nanoparticles, as well as the lowest detectable heat flow of DSC. The heat energy (Q) can be
derived from the mass (m) and the heat of fusion (ΔHfus) of phase change nanoparticles using the
following equation:
Q  m  H fus

(1)

For indium nanoparticles, the latent heat of fusion is 28.5kJ/kg. In the case of lead-tin alloy
nanoparticles, the latent heat is derived to be 45kJ/kg using H  xH a  (1  x) H b , where Ha and
Hb are the latent heats of two metals, and x is the mass ratio of metal A in the alloy. The minimal
detectable heat flow in DSC is determined by its root-mean-square noise (0.2 µW), which
corresponds an energy flow of 0.2 µJ for 1ºC wide melting peak at ramp rate of 1ºC/s. Assuming
that nanoparticles have uniform diameters (D), and the grafting density of DNA on nanoparticle
is α, the minimal number of the target ssDNA (n) that can be detected will be derived from:

n

3Q
4 r 3 H fus

(2)

where r is the radius of nanoparticle and ρ is the density of nanoparticles. From the equation,
nanoparticles with large diameter or large latent heat correspond to high sensitivity. Figure 2.8B
shows the relation between peak areas and target ssDNA concentrations for indium and lead-tin
nanoparticles. The peak areas corresponding to indium are larger than those of lead-tin
nanoparticles, which could be induced by the size difference and grafting density difference of
two types of nanoparticles. Equation 2 also shows that lower grafting density corresponds to less
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target ssDNA, or higher detection sensitivity. In our previous experiment on silica encapsulated
indium nanoparticles, the lowest detection limit is ~8 nM because the grafting density of DNA
on silica layer is higher. As a comparison, the slightly oxidized nanoparticles have lower grafting
density of probe ssDNA, thus higher detection sensitivity. Providing there is only one probe
ssDNA immobilized on each nanoparticle in a 1 ml solution, the accordant concentration of
target ssDNA is 3.04×10-15 moles or 3.04 fM using indium nanoparticles under the following
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conditions: r is 50 nm, Q is 0.2 µJ, and ρ is 7310 kg/m3, respectively.
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Figure 2.8 Detecting target ssDNAs in cell lysate using indium and lead-tin nanoparticles as
probes (A), the relations between peak areas and target ssDNAs concentrations for indium
(square) and lead-tin (circle) nanoparticles (B).

2.3.7 Multiplicity and peak width
The multiplicity of this detection method depends on the widths of melting peaks and the
number of different types of nanoparticles. Not only the nanoparticles of pure metals can be
used, binary or ternary alloys can be designed based on phase diagrams and produced to offer
multiple types of nanoparticles. We have prepared binary alloy nanoparticles, lead-tin, that have
controlled melting temperatures. The peak width is determined by two time constants: τi is
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instrument time constant that depends on ramp rate, measuring head, atmosphere, and crucibles;
τs is sample time constant that is a function of sample mass. Larger sample mass corresponds to
larger τs. Considering a solid nanoparticle at its phase change temperature (Tm), the melting time
depends on the size of nanoparticle and the temperature difference between the surface
temperature of nanoparticle and the melting temperature of nanoparticle material:
1  r
(Ts  Tm )  
 rp2  
 3  rp
  l Ql 



 kl 

3
2

 1 r 
     1

2  rp 
6



(3)

where Ts and Tm are the surface temperature and the melting point of nanoparticles, respectively;
τ is the melting time when the solid radius is r, rp is the radius of the nanoparticle before melting;
Ql is the latent heat of fusion of nanoparticles; kl is the thermal conductivity of nanoparticles; and
ρl is the density of nanoparticles. For the indium nanoparticles, kIn is 81.8 W·m-1·K-1, rIn is 50
nm, QIn is 28.52 kJ/kg, and ρIn is 7310 kg/m3, respectively. Replacing all the symbols with
numbers, we can derive that τ is 0.11 μs. Figure 2.9A shows the simulated melting time of a 100
nm indium nanoparticle as functions of the difference between the surface temperature and the
melting temperature of nanoparticles. From the curves, the melting time is less than 100 µs at the
ramp rate of 10ºC per minute, and the temperature difference of 0.1ºC. The contribution of
nanoparticle melting on peak width is smaller than those taken by instrument. Figure 2.9B shows
ramp rate dependent full width at half maximum (FWHM) of melting peaks measured for indium
and alloy nanoparticles. In both cases, the peak width becomes smaller as the ramp rate is
decreased. A linear relation exists between ramp rate and peak width, and the smallest peak
width among all ramp rates studied is 0.3°C. Therefore, providing a sufficient number of
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different alloy nanoparticles can be made with controlled melting temperatures, the multiplicity
of this method can be as high as 1,000 for the temperature scan range of 100 to 700ºC.
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Figure 2.9 The melting times of indium nanoparticles with diameter of 100 nm as the function of
the temperature difference between surface and melting temperature (A); the ramp rate
dependent peak width for indium (square) and lead-tin alloy (circle) nanoparticles (B).

2.4 Conclusions
We have shown the capability of thermally addressed nanoparticles for the detection of
molecular biomarkers by using phase change nanoparticles of metallic materials (i.e., pure metal
and alloy). The novel signal transduction mechanism allows the detections of multiple DNA
biomarkers in cell lysate and milk with high sensitivity, which is comparable to other
nanoparticle based methods. In addition, the melting peaks and fusion enthalpies measured from
the temperature scan processes can be used for the qualitative and quantitative detections of
biomarkers.
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CHAPTER 3: MULTIPLEXED PROTEINS DETECTION USING PHASE
CHANGE NANOPARTICLES

3.1 Introduction
Detecting protein biomarkers in complex fluids such as blood, urea, or cell lysate offers
great benefits in sample preparation and target retention for early disease detection.83-85
Enzyme-linked immunosorbent assay (ELISA) relies on antigen-antibody interaction to detect
antibodies (i.e., proteins), and the binding events are readout through enzyme activities or the
physical, chemical, or spectroscopic labels attached on the antibodies at different sites.86-88
Because of the small sizes, nanoparticles have intimate contacts with target proteins in solutions
and have been used to detect specific antigen-antibody interaction,89-92 where the sensitivity is
enhanced by amplifying the physical signatures of nanoparticles. Although widely used, ELISA
has some limits: (1) it requires extensive efforts and expensive agents to produce testing samples
that are free of colored species, suitable pH, and salt concentration; species that interfere with the
activity of enzyme should be removed; (2) the multiplicity is often low, even if nanoparticles are
used as probes, which makes it hard to detect multiple proteins from a small amount of sample.
In this aspect, although optical absorbances of metallic and semiconductor nanoparticles can be
controlled in the range of 400-900 nm by changing diameters,93 the absorbance or emission
peaks in this region are wide (∼150 nm), which limits the number of biomarkers that can be
detected in one assay due to peak overlap.94 Metal or magnetic nanoparticles cannot be used to
detect multiple proteins because different nanoparticles are not distinguishable by their electric
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or magnetic properties.95-98 The electrochemical method can detect a few types of nanoparticles
but the peaks are wide and the voltage range is narrow (few voltages), which limits its detection
multiplicity.99
We describe a novel technique that depends on the solid-liquid phase transitions of
nanoparticles to detect multiple proteins. In this thermally addressed immunosorbent assay
(TAISA), pure metal or alloy nanoparticles with a variety of compositions and melting
temperatures are made by the colloidal method and modified by antibodies. A solid surface (i.e.,
aluminum) is also modified by antibodies;100 the aluminum surface is immersed in a solution that
contains the target antigen. After washing, the aluminum surface is immersed in a solution
containing nanoparticle-labeled antibody (Figure 3.1). In this sandwich detection configuration,
the thermal property of the immobilized nanoparticles is directly measured rather than that of the
antigen-antibody interaction. The signal transduction is based on a known but unexplored
phenomenon: the temperature of a single component solid does not rise over its melting point
until the entire solid is molten,101 thus the melting peak of the solid is sharp after a linear
temperature rise process. A one-to-one correspondence can be created between the melting point
of one type of nanoparticles and one type of protein. The melting temperature and the heat flow
are used to distinguish and quantify the nature and concentration of the protein. Because the
melting temperature of the nanoparticles can be designed to be higher than those of the species
contained in samples, the method is immune to colored or conductive species. In addition, the
method can detect multiple proteins due to sharp melting peaks and multiple choices of phase
change materials (i.e., metal, alloy, polymer, and salt). In a typical thermal scan from 20 to 700
°C, the number of different types of nanoparticles that can be detected in one run will reach 1000
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if the peak width at half-maximum is 0.6 °C, meaning that the method has a high level of
multiplicity.

Figure 3.1 Schematic illustration of thermally-addressed immunosorbent assay.

3.2 Experimental and methods
3.2.1 Synthesis of phase change nanoparticles
All chemicals used in this experiment are obtained from Sigma-Aldrich. The phase
change nanoparticles of pure metals and alloys such as indium, tin, and lead-tin alloy
nanoparticles are prepared by thermal decompositions of organometallic precursors.102-104 The
precursors are dissolved, or two types of precursors are mixed at a stoichiometric ratio and
dissolved into ethylene glycol (EG) in the presence of polyvinyl-pyrrolidone (PVP). These
precursors are decomposed at 200 °C under protection of nitrogen. After reacting for 30 min, the
reactions are quenched by pouring the liquid into 200 mL of ethanol that is precooled at 0 °C.
Then the nanoparticles are separated by using centrifugation, washed by ethanol three times, and
dried with nitrogen flow for future use.
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3.2.2 Nanoparticle characterizations
A ZeissUltra 55 scanning electron microscope (SEM) working at an accelerating voltage
of 10 kV is used to image nanoparticles that are dispersed from suspension onto a conductive
silicon surface. The compositions of nanoparticles are confirmed by an energy dispersive X-ray
(EDX) detector. A JEOL 1011 transmission electron microscope (TEM) that is operated at 100
kV is used to image the nanoparticles. The melting temperatures and the fusion enthalpies of
nanoparticles are measured by using a differential scanning calorimeter (PerkinElmer DSC 7). A
total of 5 mg of nanoparticles is sealed inside an aluminum pan and tested from 50 to 300 °C at a
temperature ramp rate of 10 °C/min. An empty aluminum pan is used as reference to determine
the difference in heat flow of the sample and the reference. The differential scanning calorimetry
(DSC) experiments provide heat fluxes in both melting and crystallization processes, but only
melting curves are used in this work. The enthalpies of fusion of the nanoparticles are derived
from peak areas using the data analysis software of the DSC instrument. From the latent heats of
fusion, the amount of phase change nanoparticles can be derived. The melting temperatures of
indium, lead-tin, and tin nanoparticles are determined to be 156, 183, and 230 °C, respectively,
which are the same as the bulk counterparts because of the large diameters.105-107 Lead-tin alloy
nanoparticles at the eutectic compositions have also been prepared by this method. The size and
shape of indium and lead-tin alloy nanoparticles has been characterized by TEM and it has been
mentioned in chapter 2 and section 2.3.1. For tin nanoparticles, Figure 3.2A shows a typical
TEM image and it shows that the nanoparticles have the size of about 100 to 200nm. Figure 3.2B
shows the DSC curve of tin nanoparticles, it shows that the melting temperature of tin
nanoparticles is about 231°C. The crystallized structures of nanoparticles at room temperatures
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have been confirmed by selected area electron diffraction (SAED). Some of the characterization
results such as SEM images, SAED patterns, and DSC curves can be found in our previous
papers.108
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Figure 3.2 (A) TEM image of tin nanoparticles; (B) DSC curve of tin nanoparticles.

3.2.3 Surface modification of nanoparticles
The surface modifications of nanoparticles are carried out as follows. The lead-tin
nanoparticles are dried and heated to 100 °C in an oven in atmosphere, which produces thin
layers of oxide around nanoparticles. The existence of a thin oxide layer has been verified by
using energy dispersive X-ray analysis (EDX), which has been shown in Figure 3.3A. The oxide
layer of the nanoparticle is amine-modified by incubating in 10% (aminopropyl) triethoxysilane
(APTES) in toluene for 1 h at room temperature, which is followed by washing in toluene and in
PBS solution. The surface modification of nanoparticles is confirmed by using fluorescent
labeled bovine serum albumin proteins (BSA), which are covalently immobilized onto
nanoparticles using a bifunctional cross-linker, disuccinimidyl suberate (DSS). Figure 3.3B
shows a fluorescent image of BSA modified lead-tin nanoparticles. Furthermore, we have shown
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the surface oxidation of lead-tin thin films at the same heating conditions, where the thin film is
patterned to indicate fluorescent contrast. Lead-tin thin films are deposited onto silicon surfaces
using electron beam evaporation. Then thin layers of photoresist are spun onto the films and
exposed with UV light through a photo mask that has patterns. After development of exposed
portions, the films are treated in APTES vapor at 100 °C, which is followed by removing
unexposed photoresist. In the next, fluorescent BSA proteins are immobilized onto
amine-modified surfaces by using DSS as crosslink. The micropattern on the lead-tin thin film
can be seen under a fluorescent microscope as shown in Figure 3.3C, confirming the oxidization
and modification of the lead-tin film. Similar modifications have been done on thin films of tin
and indium.
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Figure 3.3 (A) EDX collected from surface-oxidized lead-tin nanoparticles; (B) a fluorescent
image of BSA modified lead-tin nanoparticles; (C) a fluorescent micro-pattern on the lead-tin
thin film.

3.2.4 Surface modification of aluminum surfaces
In order to immobilize ligands on surface, the native oxide film on an aluminum surface
is modified by putting the surface in a small vial that contains 0.1 mL of APTES. The vial is then
heated in an oven at 100 °C for 1 h. The APTES vapor will condense and react with oxide
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surface to form an amine-terminated monolayer. The EDX spectrum confirms the oxidation and
modification of aluminum. Figure 3.4A and 3.4B show the EDX spectra of aluminum surface
before and after modification by APTES, respectively. The oxygen characteristic absorption
peak in Figure 3.4A verified an aluminum oxide thin layer coated on the aluminum surface,
while the silicon and nitrogen absorption peak in Figure 3.4B confirmed the successful chemical
modification of the aluminum surface by APTES. The surface modification has also been further
confirmed by immobilizing fluorescent BSA proteins on an aluminum surface with
micropatterns. After the surface was washed with dimethyl sulfoxide (DMSO), the
amine-terminated surface is immersed in an anhydrous DMSO solution containing DSS for 1 h.
The surface is washed three times using DMSO and phosphate buffered saline (PBS),
respectively, and then incubated with fluorescent labeled BSA protein in PBS for 2 h. The
unreacted proteins are removed by washing thoroughly with PBS. Figure 3.4C shows the
fluorescent micropatterns on the aluminum surface. It is clearly suggesting the successful
modification of the aluminum surface after following our surface modification procedure.

1500
O

800

900
600
300
0
0.0

Al

Counts

Counts

1200

1000

A

0.4

0.8

1.2

KeV

1.6

2.0

C

O

600
400
Al

200

C

B

0
0.0

C
Si

N

0.4

0.8

1.2

KeV

1.6

2.0

Figure 3.4 EDX spectrum collected from an aluminum surface before (A) and after (B) modified
by APTES; (C) a fluorescent micro-pattern on the aluminum surface.
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3.3 Results and discussion
3.3.1 Thermal detections of avidin in buffers
The thermally address method is used to detect avidin in buffer by using phase change
nanoparticles of indium and lead-tin alloy. The nanoparticles are modified to have amine groups.
The aluminum surface with native oxide is also modified to have amine groups. The
amine-modified nanoparticles and the aluminum surfaces are conjugated with biotins by
incubating with amine reactive biotinylation reagent (NHS-LC-biotins) in anhydrous DMSO for
1 h at room temperature, which is followed by washing in DMSO and in PBS. The avidin
detection is carried out by incubating the biotin modified aluminum surface in solutions that
contain avidin at certain concentrations for 1 h. The surface is then incubated in biotin modified
nanoparticles for 1 h after rinsing. Unconjugated nanoparticles are rinsed away, and immobilized
ones are readout using DSC. Figure 3.5A shows the DSC curves of indium nanoparticles
immobilized on aluminum surfaces at different avidin concentrations, where the thermal scan is
carried out from 50 to 300 °C at a ramp rate of 10 °C/min. The single melting peaks at 156 °C
confirm that indium nanoparticles have been immobilized onto aluminum surfaces. The
measured heat flows decrease as the concentrations of avidin decrease (Figure 3.5B).
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Figure 3.5 DSC curves (A) and concentration dependent heat flows (B) of indium nanoparticles
that are immobilized on aluminum surfaces through biotin-avidin interaction, where the curves
from up to down are at avidin concentrations of 20, 2, and 0.05 ng/mL, respectively.

Similarly, we have also used lead-tin nanoparticles (atomic ratio of 63:37) to detect
avidin in buffers. The avidin detection is carried out by incubating the biotin modified aluminum
surface in solutions containing different concentrations of avidin for 1 h. The surface is
incubated in biotin modified lead-tin nanoparticles for 1 h after rinsing. After the aluminum
surface is rinsed, the thermal signatures of lead-tin alloy nanoparticles are read out using DSC at
a ramp rate of 10 °C per min. Figure 3.6A shows the DSC curves of the lead-tin alloy
nanoparticles immobilized on aluminum surfaces at different avidin concentrations, where
nanoparticles melt at 183 °C, and the heat flows decrease linearly as avidin concentration
reduces (Figure 3.6B).
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Figure 3.6 DSC curves (A) and concentration dependent heat flows (B) of lead-tin nanoparticles
that are immobilized on aluminum surfaces through biotin-avidin interaction, where the curves
from up to down are at avidin concentrations of 200, 20, 0.5, and 0.2 ng/ml, respectively.

3.3.2 Thermal immunoassay in buffers
The thermal immunoassay using phase change nanoparticles is carried out as follows.
The amine-modified nanoparticles and the aluminum surface are conjugated to anti-rabbit IgG by
incubating them with DSS in anhydrous DMSO in PBS (pH of 7.4) for 2 h. The nanoparticles
and the aluminum surface are then washed by PBS to remove excess DSS. The anti-rabbit IgG
modified aluminum surface is incubated in solutions containing rabbit IgG at a certain
concentration for 1 h. The surface is incubated in anti-rabbit IgG modified lead-tin nanoparticles
for 1 h after rinsing. After the aluminum surfaces are rinsed, the lead-tin nanoparticles are read
out using DSC. Figure 3.7A shows the melting peaks of lead-tin nanoparticles immobilized at
different concentrations of rabbit IgG. The crossreactivity (selectivity) has been checked by
human IgG (bottom curve), where 20 ng/mL human IgG does not lead to immobilization of
nanoparticles. Figure 3.7B shows that the heat flow is proportional to the concentration of rabbit
IgG.
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Figure 3.7 DSC curves (A) of lead-tin nanoparticles at 200, 20, 2, and 0.5 ng/ml (top to down) of
rabbit IgG; 20 ng/ml of human IgG does not cause attachment of nanoparticles (flat line); the
relation between the heat flow (peak area) and rabbit IgG concentration (B).

In addition, human IgG in buffer is detected using tin nanoparticles in PBS (pH of 7.4).
The surfaces of tin nanoparticles and aluminum surfaces are first modified with antihuman IgG.
The antihuman IgG modified aluminum surface is incubated in solutions containing human IgG
at a certain concentration for 1 h. The surface is incubated in antihuman IgG modified
nanoparticles for 1 h after rinsing. Figure 3.8A shows the melting peaks of tin nanoparticles
immobilized on aluminum surfaces at several human IgG concentrations, where the
nanoparticles melt at 230 °C and the heat flows decrease as the concentrations of human IgG
reduce (Figure 3.8B). Each DSC curve is flattened by using the commercial software of the DSC
instrument to remove the slope, which is induced by a heat transfer difference between the
sample cell and the reference cell.
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Figure 3.8 DSC curves (A) of tin nanoparticles that are immobilized at 2, 0.5, and 0.2 ng/ml (top
to down) of human IgG; the relation between the heat flow and human IgG concentration (B)
after immobilization of tin nanoparticles

3.2.3 Multiplexed thermal immunoassay in buffers
The multiplicity of thermal detection is reflected in the simultaneous detection of rabbit
IgG and human IgG, where lead-tin nanoparticles and tin nanoparticles are modified with
anti-IgGs of the rabbit and human, respectively. In order to modify aluminum surfaces, both
anti-IgGs of the rabbit and human are mixed at the same molar ratio and immobilized on
amine-ended aluminum surfaces. The multiplexed detection is done by incubating the modified
aluminum surface in a mixture that contains 2 ng/mL rabbit IgG and 2 ng/mL human IgG in PBS
(pH 7.4) for 1 h. After the surface is rinsed, it is incubated in a mixture of two types of modified
nanoparticles for 1 h. The aluminum surface is tested by DSC after rinsing for a second time.
Figure 3.9A shows two melting peaks of tin and lead-tin nanoparticles at 183 and 230 °C,
respectively. The difference in the heat flows of the two peaks may be induced by differences in
latent heats of indium and lead-tin alloy with sizes of two types of nanoparticles or grafting
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densities of anti- IgGs on them. The one-to-one correspondence created between protein and
melting temperature allows the detection of multiple proteins in one experiment.
The multiplicity of the thermal method is dependent on the sharpness of individual peaks
due to the issue of peak overlap. Figure 3.9B shows the relation between the ramp rate and the
peak width at half height of the indium nanoparticles, where the peak width is proportional to the
ramp rate and the minimal peak width is 0.6 °C. Considering the composition-dependent melting
temperatures of alloys, nanoparticles with different melting temperature can be designed to have
a large number of melting peaks based on phase diagrams. The sharp melting peaks, combined
with the large number of different melting peaks of nanoparticles, enhance the multiplicity of
detection by operating DSC at a low ramp rate.
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Figure 3.9 DSC curve of the multiplexed detection of 2 ng/mL of human IgG and 2 ng/mL of
rabbit IgG using tin nanoparticles and lead-tin nanoparticles, respectively (A); ramp rate
dependent peak width for indium nanoparticles (B).
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3.2.4 Thermal immunoassay in cell lysate
The thermal immunoassay has been carried out in a complex cell lysate of human breast
cancer cells. The cell lysate contains a certain amount of human IgGs released from cell
membranes. At first, rabbit IgGs are added at a certain concentration in diluted cell lysates (total
protein concentration is determined to be 1 μg/mL). The anti-rabbit IgG modified aluminum
surfaces are incubated in solutions containing different concentration of rabbit IgG for 1 h. The
surface is incubated with anti-rabbit modified nanoparticles for 1 h after rinsing. After the
surface was rinsed again, the thermal signatures of the lead-tin nanoparticles are read out using
DSC at a ramp rate of 10 °C/min. Figure 3.10A shows the DSC curves of lead-tin nanoparticles
immobilized on aluminum surfaces at different rabbit-IgG concentrations, where the heat flows
decrease as the concentration of rabbit IgG decreases (Figure 3.10B).
The concentration of human IgG in the diluted cell lysate (total protein concentration of 1
μg/mL) is determined by using antihuman IgG modified lead-tin alloy nanoparticles and
aluminum surfaces. The surface modifications are carried out by using the same method as
before. The antihuman IgG modified aluminum surface is incubated in the lysate for 1 h. The
surface is incubated with antihuman IgG modified lead-tin nanoparticles for 1 h after rinsing.
Then the aluminum surfaces are taken out, washed using PBS to remove excess nanoparticles,
and analyzed using DSC at a ramp rate of 10 °C/min. Figure 3.10C shows the melting curve of
lead-tin nanoparticles immobilized on the aluminum surface. From the peak area, the
concentration of human IgG in the dilute lysate (1 μg/mL total protein) is determined to be 182
ng/mL. As a rough comparison, 20% of proteins contained in normal human serum are IgG.109 If
this value is valid for the human cancer cells in this study, the estimated concentration of human
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IgG (with total protein concentration of 1 μg/mL) would be 200 ng/mL, which is as the same
order as the value we have derived using lead-tin nanoparticles.
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Figure 3.10 DSC curves (A) and concentration dependent heat flow (B) of lead-tin nanoparticles
that are immobilized on aluminum surfaces by anti-rabbit-IgG and rabbit IgG interaction in
diluted cell lysate, where rabbit IgG is intentionally added into the complex liquid at
concentrations of 20, 10, and 2 ng/mL (top to bottom); DSC curve of lead-tin nanoparticles that
are immobilized by human IgG contained in the diluted cell lysate (C).

3.4 Conclusions
In conclusion, we have shown the multiplexed detection of proteins using solid-liquid
phase change nanoparticles as thermally addressed barcodes. A one-to-one correspondence is
established between the type of nanoparticles and the type of proteins, thus multiple proteins can
be detected simultaneously by using a combination of nanoparticles. The sensitivity can be
further enhanced using nanoparticles with a large latent heat of fusion and reducing the grafting
density of the antibody on the nanoparticle. The melting peak and heat flow reflect the nature
and concentration of the protein, respectively. The melting temperature of the nanoparticles can
be designed to avoid interference from coexisting species in samples, thus bringing high
sensitivity and multiplicity and sample preparation benefits to the early detection of proteins. At
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last, the method is generic and can be used for the detection of disease markers in various body
fluids.
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CHPATER 4: HIGHLY-SENSITIVE THERMAL DETECTION OF
THROMBIN USING APTAMER-FUNCTIONALIZED PHASE CHANGE
NANOPARTICLES

4.1 Introduction
Thrombin is one kind of physiological protease found in the blood, which can convert
soluble fibrinogen into insoluble strands of fibrin, causing blood clotting. Thrombin is also
involved in a number of biological processes such as cardiovascular diseases, metastasis,
angiogenesis, regulation of tumor growth, and has been used as a biomarker for tumor
diagnosis.110-112 The concentration of thrombin in blood can change considerably from nM to low
μM levels; in patients with coagulation abnormalities thrombin circulates at much lower
concentration at pM level.113, 114 For the cancer marker thrombin-antithrombin (TAT) complex,
the concentration of thrombin in blood samples is as low as 2.0 ng/ml.115 Developing an assay
with high sensitivity, selectivity, and simplicity for thrombin detection can greatly facilitate the
diagnosis and cure of related diseases.
Enzyme-linked immunosorbent assay (ELISA) has been widely used for sandwiched
detections of proteins, where specific antibodies are immobilized onto a substrate to capture
target proteins; another antibody is then attached onto the other side of proteins to report the
binding event.116-119 Instead of using antibodies that are delicate to handle, target proteins can
also be captured by DNA and RNA aptamers, which are single-stranded nucleic acids that can
bind to protein targets with high specificity. Aptamers can be selected from random libraries
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using an in vitro evolution process known as SELEX or systematic evolution of ligands by
exponential enrichment.120-122 Compared to conventional antibodies, aptamers offer certain
advantages in terms of high binding specificity, good stabilization, low cost, ease of preparation,
storage and modification.123-126 The signal transductions after binding of aptamers or antibodies
are based on the physical, chemical or biological properties of reporting probes, and can be
amplified thereafter to achieve high sensitivity. Until now, various aptamer-based sensors have
been used for thrombin detection. These sensors depend on well-established signal transduction
mechanisms such as optical transduction, mass spectroscopy, fluorescence, colorimetry and
electrochemistry.127-136 Microfluidic devices have also been used for aptamer-based thrombin
detection.137 Although successful from one or more aspects of detection, most of these
techniques suffer from complexity, reliability, selectivity and sensitivity issues.
The advent of nanostructured materials has brought many opportunities to dramatically
enhance sensitivity of bio-detections. Because of their unique electrical and optical properties,
nanoparticles-based materials have provided excellent prospects for chemical and biological
sensing.138, 139 Metal nanoparticles, with controlled size, shape, and structure can be made using
simple colloid-chemical methods.140-142 The surface properties of nanoparticles can be
engineered,

and

appropriate

ligands

can

be

conjugated

through

various

surface

modifications.143-146 Owing to their small size and large surface area, nanoparticles can have
intimate contact with target analytes in solution. After immobilizing specific ligands (i.e.,
aptamers or antibodies) onto nanoparticles, the specific binding can be readout through changes
in the physical, chemical, or biological properties of the reporting probes. The biological
recognition events are converted to physical signals that can be amplified to reflect the presence
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and the amount of target molecules.147, 148 But, existing nanoparticle based detection methods
(except magnetic nanoparticle one) need extensive sample preparation efforts to remove colored
or interference species prior to analysis; otherwise, errors from sample preparation will be
overwhelming, resulting in the reduction of detection performance. In particular, for thrombin
detection in strongly colored blood samples, thrombin can stick irreversibly onto container walls
or be lost during sample handling. An ideal way for thrombin detection would be one that
requires less effort for sample preparation and at the same time offer high sensitivity and high
specificity.
We report a new nanoparticle-based scanning calorimetric method for thrombin detection
by using aptamer-functionalized phase change nanoparticles as thermal probes. The signal
transduction is based on the thermal properties of nanoparticles by utilizing a well-known, but
unexplored phenomenon: namely, the temperature of a bulk solid will not rise above its melting
point until all solid is molten completely. In this method, the melting enthalpy of nanoparticles is
directly measured instead of that of aptamer-protein interaction. The position and area of the
melting peak are used to recognize and quantify the presence and amount of thrombin,
respectively. This method is immune to colored species (red blood cells) in sample, and can be
performed in blood samples directly. Briefly, nanoparticles of low melting point materials are
modified with thrombin aptamer; flat substrates (aluminum or filter paper) and nanostructured
substrates (silicon nanopillar array) are also modified by aptamer; the aptamer modified surface
is immersed into a buffer solution or fetal calf serum buffer solution that contains thrombin; the
binding of aptamer modified nanoparticles with thrombin results in immobilization of the

57

nanoparticles in sandwiched configuration, where the nanoparticles can be readout easily using a
differential scanning calorimetry (DSC) (Figure 4.1).

Figure 4.1 Thermal detection of thrombin using aptamer-functionalized phase change
nanoparticles.

4.2 Experimental sections
4.2.1 Chemicals and materials
Human thrombin, fluorescein isothiocyanate-labeled bovine serum albumin (FITC-BSA),
indium acetate, ethylene glycol, and polyvinylpyrrolidone were purchased from Sigma-Aldrich
(St. Louis, MO). The thrombin aptamer with sequence of 5'-AmMC6-TTT TTT TTT TTT TTT
GGT TGG TGT GGT TGG-3' was designed using systematic evaluation and obtained from IDT
(Coralville, IA). The aptamer was dissolved in pH 7.4 phosphate saline (PBS) buffer (0.01 M in
phosphate, 0.14 M NaCl, 2.7 mM KCl) unless otherwise noted. Anhydrous dimethyl sulfoxide
(DMSO), Whatman filter paper (grade 1), toluene, 3-aminopropyltriethoxysilane (APTES),
hydrogen peroxide (H2O2), sulfuric acid (H2SO4), and hydrogen fluoride (HF) were obtained
from VWR (West Chester, PA). Disuccinimidyl suberate (DSS) was obtained from Thermo
Scientific (Waltham, MA). Surfactant free carboxyl-modified polystyrene (PS) suspension (400
nm of diameter) containing 4% solid, and fetal calf serum were obtained from Invitrogen
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(Carlsbad, CA). Ultrapure water (18.2 MΩ cm) purified by nanopure System (Barnstead,
Kirkland, WA) was used throughout the experiments. All chemicals used in this study were
analytical reagent grade.
4.2.2 Synthesis and characterization of phase change nanoparticles
Phase change indium nanoparticles with melting temperature of 156ºC were made by
thermal decomposition of organometallic precursors (indium acetate). The precursor and
polyvinylpyrrolidone (molecular weight of 11000) were dissolved in ethylene glycol and stirred
for 10 minutes to make a homogeneous solution. After the mixture was refluxed at 200°C for 20
minutes to decompose precursors under nitrogen protection, the product was quenched by
pouring the mixture in ethanol pre-cooled at 0°C. The as-prepared nanoparticles were
centrifuged at 3000 rpm for 10 minutes. After removing supernatant, the nanoparticles were
resuspended in ethanol and centrifuged again. This process was repeated three times to ensure
that nanoparticles were clean. A JEOL 1011 transmission electron microscope (TEM) operated
at 100 kV was used to derive the size and shape of the synthesized nanoparticles. A Zeiss Ultra
55 scanning electron microscope (SEM) at accelerating voltage of 10 kV was used to image
nanoparticles. The compositions of nanoparticles were analyzed by using an energy dispersive
X-ray (EDX) detector.
4.2.3 Fabrication of nanostructured Si surfaces
Silicon nanopillar arrays with high aspect ratio were created by a metal assisted etching
method.149 Briefly, single crystal silicon (100) wafer (p-type, Boron-doped, resistivity of 8-25
Ω·cm) was treated at 80ºC for 1 hour in piranha solution that contained 3:1 (v/v) concentrated
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H2SO4:30% H2O2, and rinsed with deionized water to remove contamination from organic grease.
Subsequently, the silicon substrates were sonicated in 5:1:1 H2O/NH4OH/H2O2 for 60 minutes
and washed with a large amount of deionized water. After treatment, the substrates became very
hydrophilic due to the production of hydroxyl groups. The treated substrates were stored in
deionized water and used within one week. In order to form nanosphere mask, a droplet of
polystyrene nanospheres solution at original concentration were dropped onto a cleaned silicon
substrate and allowed to dry, forming a monolayer in a close-packed hexagonal structure. The
nanosphere monolayer coated substrates were then treated by oxygen plasma for various times
ranging from 5 to 15 minutes. The purpose of oxygen plasma treatment was to reduce the
particle size and make a mask for metal deposition. A thermal evaporator (Denton) was used to
deposit a 10 nm gold film onto the substrates in vacuum at a pressure lower than 5.0×10 -6 Torr.
Following gold deposition, the polystyrene nanospheres were removed by dissolution in
chloroform (CHCl3) to create an ordered array of nanoholes, where the diameters of holes were
determined by the diameter-reduced polystyrene nanospheres. At last, silicon under gold was
etched in a mixture of deionized water, 10 wt% HF and 1.5 wt% H2O2, and then rinsed with
ethanol and deionized water for 20 seconds, respectively.
4.2.4 Surface modification of phase change nanoparticles
The surface modification of nanoparticles was carried out as following. The as-prepared
indium nanoparticles were put into an oven and kept at 110ºC in ambient condition for 10
minutes, which produced a thin oxide layer around the nanoparticles. The nanoparticles with
thin oxide films were modified with amine-terminated monolayer by immersing in a 5%
APTES/toluene solution for 1 hour at room temperature, followed by washing with toluene and
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DMSO for three times, respectively. The APTES modified nanoparticles were resuspended in a
DMSO solution containing DSS for 1 hour. After removing excess DSS by centrifugation and
washing by a buffer solution (PBS, pH 7.4) for three times, the nanoparticles were incubated in
500 µl of 60 μM thrombin aptamer in PBS for another 2 hours.
4.2.5 Surface modification of substrates
The aluminum surfaces and filter paper were modified with APTES, where the surfaces
were kept in a sealed vial containing a ~50 μl droplet of APTES, and heated up to 110 ºC for 1
hour. Then the amine-terminated surfaces were immersed in a DMSO solution containing DSS
for 1 hour. After washing with DMSO and PBS, the modified aluminum surface or filter paper
was immersed in a PBS solution containing certain amount of thrombin aptamer for 2 hours.
Unbounded oligonucleotides were removed by rinsing thoroughly with PBS (pH 7.4). The
aptamer-modified surfaces were incubated with thrombin at different concentrations in a buffer
solution, containing 34 mM Tris-HCl (pH of 7.4), 233 mM NaCl, 8.5 mM KCl, 1.7 mM CaCl2,
1.7 mM MgCl2, 8.5% glycerol (v/v), for 1 hour. After washing by PBS, the surface with
immobilized thrombin was exposed to aptamer functionalized nanoparticles in PBS for another 1
hour. The substrates were then rinsed thoroughly with PBS and dried for thermal detection.
The silicon nanostructured substrates were first treated by a mixture of H2SO4 and H2O2
at volume ratio 3:1 for 1hour at 80ºC washed thoroughly with deionized water and modified with
amine-terminated monolayer by incubating in 5% APTES ethanol solution for 1 hour. After
rinsing with ethanol and DMSO, the amine-terminated silicon substrates were immersed in a
DMSO solution containing DSS for 1 hour. The substrates were then washed with DMSO and
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PBS for three times, respectively, and incubated with thrombin aptamer in PBS for 2 hours. In
the next, the surface with immobilized thrombin was exposed to aptamer functionalized
nanoparticles in PBS for another 1 hour. The substrates were then rinsed thoroughly with PBS
and dried for thermal detection.
4.2.6 Thermal readout of thrombin-immobilized nanoparticles
A PerkinElmer DSC (DSC 7) was used to measure the melting temperatures and fusion
enthalpies of phase change nanoparticles. For nanoparticle characterization, 10 mg of
nanoparticles was sealed in an aluminum pan and the DSC test was carried out from 50 to 200°C
at a ramp rate of 10°C per minute. An empty aluminum pan was used as reference to derive the
difference in heat flows of sample and reference. For thrombin detection, the aluminum surface
was also modified with a monolayer of amine-terminated molecules using APTES. In order to
capture thrombin from solution, thrombin aptamer was immobilized onto amine-terminated
aluminum surfaces using DSS as cross-linker. Once thrombin was immobilized, the aluminum
surface was exposed to aptamer functionalized phase change nanoparticles in PBS for 1 hour.
After rinsed with PBS and dried, the substrates were ready for thermal readout.
4.3 Results and discussion
4.3.1 Nanostructured Si surface
The procedure for the fabrication of silicon nanopillar arrays has been described in
experimental section of 2.3. The morphologies of the resulting structures created on silicon
substrates are studied by a Zeiss Ultra 55 scanning electron microscope (SEM) at accelerating
voltage of 10 kV. Figure 4.2A shows a SEM image of closed-packed polystyrene nanospheres
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monolayer coated on a clean silicon substrate. Figure 4.2B shows a SEM image of polystyrene
nanospheres with reduced diameter of 350 nm after etching by oxygen plasma for 5 minutes.
Figure 4.2C shows an ordered array of nanoholes on the silicon surface after evaporating 10 nm
gold thin films and removing the polystyrene nanospheres. Figure 4.2D shows a SEM image of
silicon nanopillar arrays, where the size of the nanopillars and the center-to-center distances
between them can be controlled by selecting appropriate sizes of nanospheres, and etching
condition. Some nanopillars stick together, probably because the attractive capillary force during
drying between nanopillars is larger than that needed to bend nanopillars.
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Figure 4.2 SEM image of close-packed nanospheres on clean silicon surface before (A) and after
etching in oxygen plasma for 5 minutes (B); an ordered array of gold nanoholes (C);
cross-section SEM image of silicon nanopillars after 10 minutes’ etching (D).
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4.3.2 Thrombin detection in buffer solutions on Al and filter-paper surfaces
Buffer solutions containing thrombin at concentrations from 220 to 22 nM are used as
standard samples. The aptamer functionalized surfaces are immersed in the buffers for 2 hour to
capture thrombin. After washing the surface, aptamer functionalized nanoparticles are attached
onto thrombin immobilized surfaces in buffer solution. After reacting for another 1 hour, the
aluminum surface is taken out of the solution, washed by PBS, dried and tested by DSC. The
melting peaks of phase change nanoparticles immobilized on the substrate through
aptamer-thrombin interaction are used for the qualitative and quantitative detections of thrombin.
Figure 4.3A shows melting peaks of indium nanoparticles, where the curves from top to bottom
correspond to the concentrations of thrombin from 220 to 22 nM, respectively. The peak areas
should be related to the mass of nanoparticles or the mole number of thrombin immobilized on
the substrates, and can be derived by integrating heat flow over the melting range. Figure 4.3B
shows the relation between the peak area and the concentration of thrombin.
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Figure 4.3 DSC curves of indium nanoparticles immobilized on aluminum through thrombin in
buffer solution (A); the relation between thrombin concentrations and melting peak area of
indium nanoparticles (B).

64

Similarly, filter paper can also be modified and used to detect thrombin. Figure 4.4C
shows the DSC melting peak of indium nanoparticles immobilized on filter paper, where the
curves from top to bottom correspond to thrombin concentrations from 220 to 22 nM,
respectively. The peak area reduces as thrombin concentration drops. Figure 4.4D shows the
relation between the peak area and the thrombin concentration. The detection sensitivity (22 nM)
is comparable or better than those of most existing techniques.150
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Figure 4.4 DSC curves of indium nanoparticles captured on filter paper by thrombin at different
concentrations in buffer solutions (C), where the concentration of thrombin is from 220 to 22
nM; the relation between thrombin concentrations and melting peak area of indium nanoparticles
(D).

4.3.3 Thrombin detection in buffer solutions on nanostructured Si surfaces
The detection sensitivity is dependent on the mass and the latent heat of fusion of phase
change nanoparticles immobilized on substrates. By increasing the surface area of the substrate,
the sensitivity for detection can be enhanced. Silicon surfaces with vertically-aligned
high-aspect-ratio nanopillars have been used for thermal detection. The silicon nanopillars are
modified by APTES and activated by DSS. After reacting with aptamer for 2 hours, the substrate
is immersed in a buffer solution containing different concentrations of thrombin. The aptamer
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functionalized surface is incubated with aptamer-functionalized nanoparticles in a buffer solution
containing thrombin for 1 hour. Figure 4.5A shows an EDX spectrum of indium nanoparticles,
confirming immobilization of nanoparticles on silicon nanopillars. The silicon nanopillars have
been regenerated and re-used for detection, where the immobilized nanoparticles had been
removed by annealing at 500°C for 10 minutes and immersing in piranha solution for 30
minutes. The nanoparticles can be immobilized onto the clean substrates again using the same
procedure. This process has been repeated three times without affecting detection sensitivity.
Figure 4.5B shows the melting peak of indium nanoparticles immobilized on the nanostructured
silicon surface, where the curves correspond to the thrombin concentrations from 220 to 22 nM.
The relation between the melting peak area and thrombin concentration is plotted in Figure 4.5C,
where the peak area is proportional to the concentration of thrombin in a certain range. The
surface area of a substrate with an array of nanopillars (200 nm in diameter, and 2 µm in height)
is about 10 times larger that that of a flat surface with the same size. Figure 4.5D shows the
normalized sensitivity (peak area per mm2) at different thrombin concentrations, where the
sensitivity of the nanostructured silicon surface is enhanced by four times at thrombin
concentration of 55 nM.
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Figure 4.5 EDX spectrum of silicon nanopillars after (A) immobilizing indium nanoparticles;
DSC curves of indium nanoparticles captured on silicon nanopillars by thrombin at different
concentration in buffer solution (B), where the concentration of thrombin is from 220 to 22 nM;
the relation between thrombin concentration and melting peak area of indium nanoparticles (C);
normalized sensitivity (melting peak area per mm2) versus the concentration of thrombin (D).

4.3.4 Thrombin detection in calf serum
Fetal calf serum is the portion of plasma remaining after blood coagulation, during which
process plasma protein fibrinogen is converted into fibrin and remains behind in clot, making the
detection of thrombin in plasma or blood clinically relevant. The melting temperature of indium
nanoparticles made in our experiment is higher than the coexisting specifies in calf serum, thus
the thermal readout will not be interfered by species contained in calf serum. Thrombin is added
at certain concentration (220, 110, 55 and 22 nM) into a buffered saline containing 10% calf
serum, and detected using the same method. Figure 4.6A shows the melting peaks of indium
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nanoparticles that are immobilized on aluminum surfaces after thrombin detection, where the
curves from top to bottom are collected at thrombin concentrations of 220, 110, 55, and 22 nM,
respectively. Although the temperature scan range is from 50 to 200ºC, only the thermal
behavior in the range from 148 to 164ºC is shown for display clarity. Figure 4.6B shows the
relation between the peak area and the concentration of thrombin detected on aluminum surfaces.
Figure 4.6C shows DSC curves of indium nanoparticles collected at different concentrations of
thrombin on nanostructured silicon surfaces. Figure 4.6D also shows a relation between the
measured peak area and the concentration of thrombin. The peak areas measured at different
concentration of thrombin in buffer have been compared with those in calf serum. Similar trends
are observed when the same testing conditions are used, but the peak areas measured from serum
solution are ~50% lower than that from buffer solution. In contrast to buffer solutions that have
defined composition, serum contains abundant proteins that can affect detection of thrombin
through specific interaction or non-specific adsorption, thus causing heat flow reduction.
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Figure 4.6 DSC curves of indium nanoparticles immobilized on aluminum surface after detecting
thrombin at different concentration in calf serum buffered saline (A); the relation between
thrombin concentrations and peak areas of indium nanoparticles (B); DSC curves of indium
nanoparticles captured on silicon nanopillars by thrombin at different concentrations in buffer
solutions (C); the relation between thrombin concentrations and peak areas of nanoparticles (D).

4.4 Conclusions
We have developed a scanning calorimetric method for highly sensitive detection of
thrombin by using RNA aptamer-functionalized phase change nanoparticles. The presence of
thrombin in solution leads to attachment of nanoparticles on a substrate modified with the same
aptamer. The phase changes of nanoparticles from solid to liquid are detected by measuring heat
flow after immobilization. The position and area of melting peak reflect the existence and
concentration of thrombin. High aspect ratio silicon nanopillars have shown to enhance the
detection sensitivity by four times at thrombin concentration of 55 nM. The detection sensitivity
is comparable or better than those of most existing techniques. The thermal detection can be
performed in serum because thermal readout is immune to colored species. This new technique
provides a highly sensitive, specific and low-cost method for bio-detection using aptamer based
sandwich protein assay.
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